You have misread the post JV
"We should be finding a way to get AOD to market"
I don`t believe my distain for the GRAS is misplaced, to make publication of safety data a condition is a cop out and achieves what. What about the 1000 or so trial participants that suffered no side effects. The GRAS process probably started 18mths ago and still isn`t complete, that is a real cost in terms of value lost in sales and patent life.
- Forums
- ASX - By Stock
- CZD
- using because it is safe!!!
using because it is safe!!!, page-6
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)